Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Market Cap	345.59M -25.4%
Revenue (ttm)	2.73B -16.3%
Net Income	46.64M -8.7%
EPS	0.02 -8.3%
Shares Out	2.03B
PE Ratio	7.66
Forward PE	n/a
Dividend	0.00 (1.18%)
Ex-Dividend Date	May 19, 2025

Volume	48,000
Average Volume	104,600
Open	0.1680
Previous Close	0.1700
Day's Range	0.1680 - 0.1700
52-Week Range	0.1500 - 0.2800
Beta	1.22
RSI	45.55
Earnings Date	Mar 27, 2026

About HKG:6833

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2011
• Employees: 268
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6833

Financial Performance

In 2024, HKG:6833's revenue was 2.82 billion, an increase of 11.07% compared to the previous year's 2.54 billion. Earnings were 42.05 million, a decrease of -0.72%.

Financial numbers in CNY